P4 · Lab
Insighta
What Insighta says about itself
Insighta is a USD 200 million joint venture established in 2023 between Prenetics Global and Prof. Dennis Lo of CUHK, headquartered at Hong Kong Science and Technology Park. It is commercializing Presight, a multi-cancer early detection blood test initially focused on liver and lung cancer, with commercial launch in Hong Kong and mainland China targeted for 2025, and a multi-cancer (10-plus) version planned for 2027. This is described as the largest private life sciences deal in Hong Kong history.
Source: insighta.com, the organization's own site.
What the Atlas verified
Insighta is one of 309 organizations recorded in the Atlas of the Healthspan Economy, one of 9 in Hong Kong SAR and one of 106 in Asia.
Insighta has been a joint venture of Prenetics Global Limited.
Relationships
Key people
- Prof. Dennis Lo (Chairman, inventor of cell-free DNA diagnostics); Danny Yeung (CEO)